BRAIN TUMOR, PRIMARY
Clinical trials for BRAIN TUMOR, PRIMARY explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, PRIMARY trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 08:49 UTC
-
New MRI dye shows promise for spotting brain tumors
Diagnosis CompletedThis study tested a new contrast agent called Elucirem (gadopiclenol) for MRI scans of brain gliomas. It involved 138 adults with new or returning brain tumors. The goal was to see if Elucirem produced better quality images than the standard agent Dotarem. Results showed Elucirem…
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden brain tumors
Knowledge-focused CompletedThis study tested whether a dye called indocyanine green can make brain tumor cells glow during surgery, helping surgeons see and remove them more completely. 363 adults with brain tumors received the dye before surgery, and special cameras were used to detect the glow. The goal …
Matched conditions: BRAIN TUMOR, PRIMARY
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC